11-04 :: April/May 2011

nanotimes

Companies Facts

35

technicians to supervise and train University interns as well as their award winning CermaClad™ high energy density, large area, high speed cladding tech- nology to apply these advanced coatings to various metal surfaces.

MesoCoat is a venture-backed nanotechnology ma- terials science company fast becoming a world leader in metal protection and repair through their revolu- tionary “long life” coating and “high speed” cladding technologies. The Company was a wholly owned subsidiary of Powdermet. In late 2009, MesoCoat sold a 34% interest to Abakan. With the latest round investment, Abakan’s interest in MesoCoat will incre- ase to over 71%.

http://mesocoat.com http://www.youtube.com/watch?v=W-PDbZWCKYI

M

olecular Targeting Technologies, Inc., (MTTI) has obtained an exclusive license from the

Massachusetts General Hospital for novel fluore- scence dyes developed by Scott Hilderbrand, Ph.D. Fangwei Shao, Ph.D., and Ralph Weissleder, Ph.D. M.D.

MTTI is a privately held US based biotechnology company founded to develop novel medical ima- ging products such as PSVue®

is the imaging of

for the diagnostic and

molecular imaging of cancer and bacterial infections. A leading indication for PSVue®

tumor cell death in response to chemotherapy. Early assessment of therapy at the molecular level would allow a change of treatment when therapy is inef- fective, thereby limiting unnecessary treatment and associated costs. In addition, MTTI develops fluore- scent probes and other research tools for use by the